These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 21953377)

  • 1. Are either or both hyperuricemia and xanthine oxidase directly toxic to the vasculature? A critical appraisal.
    Neogi T; George J; Rekhraj S; Struthers AD; Choi H; Terkeltaub RA
    Arthritis Rheum; 2012 Feb; 64(2):327-38. PubMed ID: 21953377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of hydroxychalcones as multifunctional non-purine xanthine oxidase inhibitors for the treatment of hyperuricemia.
    Xie Z; Luo X; Zou Z; Zhang X; Huang F; Li R; Liao S; Liu Y
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3602-3606. PubMed ID: 28655421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compounds containing trace element copper or zinc exhibit as potent hyperuricemia inhibitors via xanthine oxidase inactivation.
    Li LZ; Zhou GX; Li J; Jiang W; Liu BL; Zhou W
    J Trace Elem Med Biol; 2018 Sep; 49():72-78. PubMed ID: 29895374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New developments in clinically relevant mechanisms and treatment of hyperuricemia.
    Lee SJ; Terkeltaub RA
    Curr Rheumatol Rep; 2006 Jun; 8(3):224-30. PubMed ID: 16901081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3,5,2',4'-Tetrahydroxychalcone, a new non-purine xanthine oxidase inhibitor.
    Niu Y; Zhu H; Liu J; Fan H; Sun L; Lu W; Liu X; Li L
    Chem Biol Interact; 2011 Feb; 189(3):161-6. PubMed ID: 21167141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary hemochromatosis disrupts uric acid homeostasis and causes hyperuricemia via altered expression/activity of xanthine oxidase and ABCG2.
    Ristic B; Sivaprakasam S; Narayanan M; Ganapathy V
    Biochem J; 2020 Apr; 477(8):1499-1513. PubMed ID: 32239172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endothelial dysfunction and hyperuricemia: role of xanthine-oxidase enzyme].
    Torres Jiménez R; García Puig J
    Rev Clin Esp; 2002 Oct; 202(10):549-51. PubMed ID: 12361555
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperuricemia and xanthine oxidase in preeclampsia, revisited.
    Many A; Hubel CA; Roberts JM
    Am J Obstet Gynecol; 1996 Jan; 174(1 Pt 1):288-91. PubMed ID: 8572024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isocytosine-based inhibitors of xanthine oxidase: design, synthesis, SAR, PK and in vivo efficacy in rat model of hyperuricemia.
    Khanna S; Burudkar S; Bajaj K; Shah P; Keche A; Ghosh U; Desai A; Srivastava A; Kulkarni-Almeida A; Deshmukh NJ; Dixit A; Brahma MK; Bahirat U; Doshi L; Nemmani KV; Tannu P; Damre A; B-Rao C; Sharma R; Sivaramakrishnan H
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7543-6. PubMed ID: 23122864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavonoids and phenylethanoid glycosides from Lippia nodiflora as promising antihyperuricemic agents and elucidation of their mechanism of action.
    Cheng LC; Murugaiyah V; Chan KL
    J Ethnopharmacol; 2015 Dec; 176():485-93. PubMed ID: 26593216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactive oxygen species derived from xanthine oxidase interrupt dimerization of breast cancer resistance protein, resulting in suppression of uric acid excretion to the intestinal lumen.
    Ogura J; Kuwayama K; Sasaki S; Kaneko C; Koizumi T; Yabe K; Tsujimoto T; Takeno R; Takaya A; Kobayashi M; Yamaguchi H; Iseki K
    Biochem Pharmacol; 2015 Sep; 97(1):89-98. PubMed ID: 26119820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Rice-Derived Short Peptide Potently Alleviated Hyperuricemia Induced by Potassium Oxonate in Rats.
    Liu N; Wang Y; Yang M; Bian W; Zeng L; Yin S; Xiong Z; Hu Y; Wang S; Meng B; Sun J; Yang X
    J Agric Food Chem; 2019 Jan; 67(1):220-228. PubMed ID: 30562028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of jianpihuashi decoction on rats with hyperuricemia].
    Chen JW; Zhou Y; Xue ZY; Li C; Guo J; Zhou LY; Jiang JM
    Zhong Yao Cai; 2013 Sep; 36(9):1486-9. PubMed ID: 24620698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemiluminescence measurements of xanthine oxidase and xanthine dehydrogenase activity in four types of cardiovascular cell.
    Bailey IA; Blackwell CP; Woodward B
    Basic Res Cardiol; 1988; 83(4):392-400. PubMed ID: 3190657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xanthine Oxidase and its Role as Target in Cardiovascular Disease: Cardiovascular Protection by Enzyme Inhibition?
    Schuchardt M; Herrmann J; Tolle M; van der Giet M
    Curr Pharm Des; 2017; 23(23):3391-3404. PubMed ID: 28413972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro Xanthine Oxidase Inhibitory Studies of Lippia nodiflora and Isolated Flavonoids and Phenylethanoid Glycosides as Potential Uric Acid-lowering Agents.
    Cheng LC; Murugaiyah V; Chan KL
    Nat Prod Commun; 2015 Jun; 10(6):945-8. PubMed ID: 26197523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of xanthine oxidase inhibitors on renal function and blood pressure in hypertensive patients with hyperuricemia.
    Kohagura K; Tana T; Higa A; Yamazato M; Ishida A; Nagahama K; Sakima A; Iseki K; Ohya Y
    Hypertens Res; 2016 Aug; 39(8):593-7. PubMed ID: 27075830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification, identification, and computational analysis of xanthine oxidase inhibitory peptides from kidney bean.
    Wu Y; He H; Hou T
    J Food Sci; 2021 Mar; 86(3):1081-1088. PubMed ID: 33565626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds.
    Xu C; Wan X; Xu L; Weng H; Yan M; Miao M; Sun Y; Xu G; Dooley S; Li Y; Yu C
    J Hepatol; 2015 Jun; 62(6):1412-9. PubMed ID: 25623823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the subpocket in xanthine oxidase: Design, synthesis, and biological evaluation of 2-[4-alkoxy-3-(1H-tetrazol-1-yl) phenyl]-6-oxo-1,6-dihydropyrimidine-5-carboxylic acid derivatives.
    Zhang B; Dai X; Bao Z; Mao Q; Duan Y; Yang Y; Wang S
    Eur J Med Chem; 2019 Nov; 181():111559. PubMed ID: 31376568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.